<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Studies of proactive penicillin skin testing in hospitalized patients</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Studies of proactive penicillin skin testing in hospitalized patients</h1>
<div class="graphic"><div class="figure"><div class="ttl">Studies of proactive penicillin skin testing in hospitalized patients</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="15%"></colgroup><colgroup width="25%"></colgroup><colgroup width="30%"></colgroup> <tbody> <tr> <td class="subtitle1">Study</td> <td class="subtitle1">Patients enrolled/tested</td> <td class="subtitle1">Penicillin skin testing (PST) results</td> <td class="subtitle1">Use of beta-lactam antibiotics as a result of PST</td> <td class="subtitle1">Study details/comments</td> </tr> <tr class="divider_bottom"> <td>Arroliga (2003<span style="white-space: nowrap;">)<sup>[1]</sup></span></td> <td>100/96</td> <td> <ul> <li>1 positive</li> <li>10 nondiagnostic</li> <li>85 negative</li> </ul> </td> <td> <ul> <li>38 patients received antibiotics</li> <li>31 of 38 received beta-lactams</li> </ul> </td> <td>Intensive care unit patients.</td> </tr> <tr class="divider_bottom"> <td>Wall (2004<span style="white-space: nowrap;">)<sup>[2]</sup></span></td> <td>26/23</td> <td> <ul> <li>1 indeterminate</li> <li>22 negative</li> </ul> </td> <td> <ul> <li>26 of 26 received a beta-lactam antibiotic</li> </ul> </td> <td>PST performed by allergist-trained pharmacist. Almost all patients (n = 22) were referred for evaluation by infectious diseases consultation.</td> </tr> <tr class="divider_bottom"> <td>Park (2011<span style="white-space: nowrap;">)<sup>[3]</sup></span></td> <td>503/71</td> <td> <ul> <li>4 positive</li> <li>67 negative</li> </ul> </td> <td> <ul> <li>29 of 71 received a beta-lactam</li> <li>Patients enrolled but not evaluated</li> <li>54 (26%) received a beta-lactam</li> </ul> </td> <td>Pharmacist screened all patients and recommended allergy consultation for PST in select patients.</td> </tr> <tr class="divider_bottom"> <td>Rimawi (2013<span style="white-space: nowrap;">)<sup>[4]</sup></span></td> <td>482/146</td> <td> <ul> <li>1 positive</li> <li>145 negative</li> </ul> </td> <td> <ul> <li>145 received beta-lactam antibiotics</li> </ul> </td> <td>Most inclusive study with about one-third of inpatients with penicillin allergy included in study. Beta-lactam antibiotics used were predominantly broad-spectrum, including piperacillin-tazobactam (n = 42), ceftriaxone (n = 27), and cefepime (n = 23). In this study, 217 patients were excluded because of uncertain allergy history, but were PST-eligible.</td> </tr> <tr class="divider_bottom"> <td>King (2016<span style="white-space: nowrap;">)<sup>[5]</sup></span></td> <td>NA/50</td> <td> <ul> <li>50 negative</li> </ul> </td> <td> <ul> <li>37 of 50 were changed to beta-lactam antibiotic</li> </ul> </td> <td>Patients were highly selected, including screened for skin test eligibility and already prescribed a broad-spectrum antibiotic.</td> </tr> <tr class="divider_bottom"> <td>Heil (2016<span style="white-space: nowrap;">)<sup>[6]</sup></span></td> <td>90/76</td> <td> <ul> <li>64 negative</li> <li>9 nondiagnostic</li> <li>3 positive</li> </ul> </td> <td> <ul> <li>54 of 64 had changed to antibiotic therapy (34 of 54 more narrow spectrum, 43 of 54 more effective therapy, 33 of 54 less costly therapy)</li> </ul> </td> <td>Skin testing service run by infectious diseases fellows and patients were highly selected through antibiotic stewardship team referral, infectious diseases consultation service, or the direct request of hospital team.</td> </tr> <tr class="divider_bottom"> <td>Chen (2016<span style="white-space: nowrap;">)<sup>[7]</sup></span></td> <td> <p>252/228</p> PST was completed in 19% of penicillin-allergic inpatients</td> <td> <ul> <li>223 negative</li> <li>5 positive</li> <li>(5 negative history only)</li> </ul> </td> <td> <ul> <li>49 patients were on a penicillin or cephalosporin before PST versus 77 after</li> <li>Active orders for broad-spectrum antibiotics decreased (vancomycin decreased 33%, clindamycin decreased 61%, quinolones decreased 36%, carbapenems decreased 50%, and aztreonam decreased 68%)</li> </ul> </td> <td>Electronic health record screened 1203 patients with penicillin allergy. Pharmacist prioritized based on patient length of stay, antibiotic therapy, and comorbidities.</td> </tr> <tr> <td>Blumenthal (2017<span style="white-space: nowrap;">)<sup>[8]</sup></span></td> <td> <p>278/42</p> Included all internal medicine patients at a tertiary care academic medical center with penicillin allergy being treated for an infection</td> <td> <ul> <li>43 negative</li> </ul> </td> <td> <ul> <li>For all enrolled patients: Odds of receiving a penicillin or cephalosporin as an inpatient were not increased as a result of this policy (adjusted odds ratio [OR] 1.3 [0.8, 2.0])</li> <li>In the subgroup of patients who were skin tested (43): Odds of receiving a penicillin or cephalosporin as an inpatient (adjusted OR 5.6 [2.5, 12.4]) and on discharge (adjusted OR 2.5 [1.04, 6.2]) were both increased</li> </ul> </td> <td>Only study that provides insight into policy impact of proactive PST with adjusted analyses.</td> </tr> </tbody></table></div><div class="graphic_footnotes">PST: penicillin skin testing; NA: not available.</div><div class="graphic_reference">References:

<ol>
<li>Arroliga ME, Radojicic C, Gordon SM, et al. A prospective observational study of the effect of penicillin skin testing on antibiotic use in the intensive care unit. Infect Control Hosp Epidemiol 2003; 24:347.</li>
<li>Wall GC, Peters L, Leaders CB, Wille JA. Pharmacist-managed service providing penicillin allergy skin tests. Am J Health Syst Pharm 2004; 61:1271.</li>
<li>Park MA, McClimon BJ, Ferguson B, et al. Collaboration between allergists and pharmacists increases beta-lactam antibiotic prescriptions in patients with a history of penicillin allergy. Int Arch Allergy Immunol 2011; 154:57.</li>
<li>Rimawi RH, Cook PP, Gooch M, et al. The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med 2013; 8:341.</li>
<li>King EA, Challa S, Curtin P, Bielory L. Penicillin skin testing in hospitalized patients with beta-lactam allergies: Effect on antibiotic selection and cost. Ann Allergy Asthma Immunol 2016; 117:67.</li>
<li>Heil EL, Bork JT, Schmaizie SA, et al. Implementation of an infectious disease fellow managed penicillin allergy skin testing service. Open Forum Infect Dis 2016; 3:ofw155. eCollection 2016.</li>
<li>Chen JR, Tarver SA, Alvarez KS, et al. A proactive approach to penicillin allergy testing in hospitalized patients. J Allergy Clin Immunol Pract 2016.</li>
<li>Blumenthal KG, Wickner PG, Hurwitz S, et al. Tackling inpatient penicillin allergies: Assessing tools for antimicrobial stewardship. J Allergy Clin Immunol 2017.</li>
</ol></div><div id="graphicVersion">Graphic 111029 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
